CA4 and breast carcinoma: Similarly with the previous studies, cis-stilbenes were more potent than the other groups of compounds, against A-549 lung carcinoma, MCF-7 breast carcinoma, HT-29 colon adenocarcinoma, SKMEL-5 melanoma, and MLM melanoma cell lines, though being a 20 times less potent than CA-4.